Biosimilar Tipping Point: Five Questions For Henlius CEO

 
• By Brian Yang
China flag with arrow graph going up showing strong economy and shares rise. Profit and success. Isolated vector illustration.
CEO Of China's Henlius Talks Biosimilar Development And Emerging Markets Strategy • Source: Shutterstock

More from China

More from Focus On Asia